Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited financial results ....
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mukka Proteins has informed BSE and NSE that its Board of Directors will meet on Wednesday, 12 November 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2025. The filing is a routine compliance disclosure under SEBI LODR Regulation 29. The company also confirmed that the trading window for designated persons and their immediate relatives is closed from 1 October 2025 until 48 hours after the results are declared. No financial figures, business update, or material decision details have been disclosed in this intimation.
This is a procedural pre-results announcement and is unlikely to move the stock on its own. Investors should watch for the actual Q2/H1 results on 12 November for any meaningful signal on revenue, margins, or profit trends.